Inden for hver frekvensgruppe er de alvorligste bivirkninger anført først.
In the table below all adverse reactions, which occurred at an incidence greater than placebo are listed by system organ class and frequency (very common (≥ 1/ 10), common (≥ 1/ 100 to < 1/ 10), uncommon (≥ 1/ 1,000 to < 1/ 100) and rare (≥ 1/ 10,000 to < 1/ 1,000)). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.